Details for 2015836431

Up to date per 05.04.2026

Actions

Title / Product Name

KRISTALLISIERUNGSVERFAHREN VON ARIPIPRAZOLDERIVATEN IN FORMULIERUNGEN MIT VERLÄNGERTER FREISETZUNG ZUR BEHANDLUNG VON SCHIZOPHRENIE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2015836431

EP Publication Number

3185867

E-Number

1354467

Language

PCT Number

US15046525

Publication Date

05.07.2017 A

13.01.2021 B1

Registration Date

13.01.2021

AT Publication Date

15.02.2021

Application Date

24.08.2015

Registration Number

Priorities

25.08.2014

201462041341 P

IPC

C07D 401/12 20060101AFI20171219BHEP

Maximum Duration of Protection

24.08.2035

Owner

Alkermes Pharma Ireland LimitedConnaught House 1 Burlington Road Dublin 4IE

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

MORALES, Wilfredo Jr.829 Oak Forest Drive Morrow, OH 45152US

ZEIDAN, Tarek A.499 Lowell Street Lexington, Massachusetts 02420US

CHIARELLA, Renato A.55 Magazine Street, Apt. 41 Cambridge, Massachusetts 02139US

WRIGHT, Steven G.7012 Juniperview Lane Madeira, Ohio 45243US

PERRY, Jason M.125 Rindge Avenue, Apt 1 Cambridge, Massachusetts 02140US

Information about Fees